Concepedia

Author

Alina Iovleva

University of PittsburghORCID

Also Known As

Alina Iovleva, Iovleva, Alina, Iovleva, Alina , Wong D.

39

Publications

1.3K

Citations

16

H-Index

10

Concepts

All Affiliations

University of PittsburghFujita Health UniversityLouis Stokes Cleveland VA Medical CenterCase Western Reserve UniversityCornell University
AI

About

Alina Iovleva is an author at University of Pittsburgh specializing in drug resistance, antibiotics, and microbiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

44

2

Medicine

1

1

44

3

Microbiology

1

1

44

4

Antibiotics

1

1

44

5

Bacterial Pathogens

1

1

44

Alina Iovleva

×

16

Publications

624

Citations

14

H-Index

YearCitations

Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in <i>Enterobacter cloacae</i> Complex Following Exposure to Cefepime

Ryan K. Shields, Alina Iovleva, Ellen G Kline,

Clinical Infectious Diseases

2020

88

Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance

Alina Iovleva, Mustapha M. Mustapha, M. Patrick Griffith,

mBio

2022

84

Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol in <i>Enterobacter cloacae</i> Due to AmpC R2 Loop Deletion

Akito Kawai, Christi L. McElheny, Alina Iovleva,

Antimicrobial Agents and Chemotherapy

2020

78

Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant <i>Acinetobacter baumannii</i> Among Patients From Different Global Regions

Minggui Wang, Lizhao Ge, Liang Chen,

Clinical Infectious Diseases

2023

72

Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment

Meredith S. Wright, Alina Iovleva, Michael R. Jacobs,

Genome Medicine

2016

71

Evolution and Transmission of Cefiderocol-Resistant <i>Acinetobacter baumannii</i> During an Outbreak in the Burn Intensive Care Unit

Steven Smoke, Alison Brophy, Samuel Reveron,

Clinical Infectious Diseases

2022

44

Genomic characterization of lytic bacteriophages targeting genetically diverse Pseudomonas aeruginosa clinical isolates

Hayley R. Nordstrom, Daniel R. Evans, Amanda Finney,

iScience

2022

33

<i>In vitro</i> activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant <i>Acinetobacter baumannii</i> collected in U.S. hospitals

Alina Iovleva, Christi L. McElheny, Erin L. Fowler,

Antimicrobial Agents and Chemotherapy

2024

21

Early initiation of three-drug combinations for the treatment of carbapenem-resistant <i>A. baumannii</i> among COVID-19 patients

Emily L. Heil, Kimberly C. Claeys, Ellen G Kline,

Journal of Antimicrobial Chemotherapy

2023

20

Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant <i>Acinetobacter baumannii</i> infections

Ryan K. Shields, Ava J Dorazio, Giusy Tiseo,

JAC-Antimicrobial Resistance

2024

20

Page 1